Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ribas

Showing results (21-30 of 5,239) with videos related to

Pageof 524
Sort By:
Current Gene Therapy|February 7, 2006
Genetically modified dendritic cells for cancer immunotherapyAntoni Ribas
Update on Cancer Therapeutics|June 23, 2009
Anti-CTLA4 Antibody Clinical Trials in MelanomaAntoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Combination Therapies Building on the Efficacy of CTLA4 and BRAF Inhibitors for Metastatic MelanomaAntoni Ribas
Journal for Immunotherapy of Cancer|May 27, 2025
Basic rules to respond to PD-1 blockade cancer immunotherapyAntoni Ribas
Cancer Discovery|May 12, 2012
Q&A: Antoni Ribas on immunotherapy progressAntoni Ribas
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2006
Update on immunotherapy for melanomaAntoni Ribas
The New England Journal of Medicine|September 9, 2015
Releasing the Brakes on Cancer ImmunotherapyAntoni Ribas
Medicina Clinica|May 8, 1993
[Clinical use of hematopoietic growth factors (hematopoietins)]M Ribas-Mundó, A Ribas Bruguera, R P Gale
Neurosurgical Focus|July 29, 2005
The anterior sylvian point and the suprasylvian operculumGuilherme Carvalhal Ribas, Eduardo Carvalhal Ribas, Consuelo Junqueira Rodrigues
Scientific Reports|March 16, 2024
The impact of rainfall on the sea surface salinity: a mesocosm studyLisa Gassen, Leonie Esters, Mariana Ribas-Ribas, et al.
Pageof 524

Showing results (21-30 of 5,239) with videos related to

Sort By:
Pageof 524
Current Gene Therapy|February 7, 2006
Genetically modified dendritic cells for cancer immunotherapyAntoni Ribas
Update on Cancer Therapeutics|June 23, 2009
Anti-CTLA4 Antibody Clinical Trials in MelanomaAntoni Ribas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Combination Therapies Building on the Efficacy of CTLA4 and BRAF Inhibitors for Metastatic MelanomaAntoni Ribas
Journal for Immunotherapy of Cancer|May 27, 2025
Basic rules to respond to PD-1 blockade cancer immunotherapyAntoni Ribas
Cancer Discovery|May 12, 2012
Q&A: Antoni Ribas on immunotherapy progressAntoni Ribas
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2006
Update on immunotherapy for melanomaAntoni Ribas
The New England Journal of Medicine|September 9, 2015
Releasing the Brakes on Cancer ImmunotherapyAntoni Ribas
Medicina Clinica|May 8, 1993
[Clinical use of hematopoietic growth factors (hematopoietins)]M Ribas-Mundó, A Ribas Bruguera, R P Gale
Neurosurgical Focus|July 29, 2005
The anterior sylvian point and the suprasylvian operculumGuilherme Carvalhal Ribas, Eduardo Carvalhal Ribas, Consuelo Junqueira Rodrigues
Scientific Reports|March 16, 2024
The impact of rainfall on the sea surface salinity: a mesocosm studyLisa Gassen, Leonie Esters, Mariana Ribas-Ribas, et al.
Pageof 524